Document Type: Original Research Article


1 chemistry

2 methodology


A general, simple, practical and convenient method has been described for the synthesis of anesthetic drug thiopental using thiourea in the presence of sodium ethoxide. Anesthetic drug of thiopental was prepared in two stages; during the first stage, the alkylation of mthyl cyanoacetate was performed which was then to be followed by cyclization. Alkylation of methyl cyanoacetate which was performed by 2-iodopentane in the presence of sodium ethoxide reacts with thiourea and then the process was followed by thiopental prepration in excellent yield. Some important aspects of this methodology are the high reactivity of the substrates, avoidance of the use of hazardous solvents, simplicity of the product separation, low cost of the substrates and reagents and high yield of product. This is a applicable and efficient method for the preparation of thiopental anesthesia in high yield and in an appropriate time.

Graphical Abstract


Click on Google Scholar  for all information of this Article in google Scholar

[1]        E.R. Garrett, J.T. Bojarski, G.J. Yakatan, Journal of Pharmaceutical Science,1971, 60, 1145-1154.

[2]         C.H. Suk Kyu, D.H. Andrew, J. Am. Chem. Soc., 1988, 110, 1318–1319.

[3]        D. Thetford, A.P. Chorlton, J. Hardman, Dyes and Pigments, 2003, 59, 185-195.

[4]        N. Harrison, W. Mendelson, H.D. Wit, Neuropsychopharmacology, 2000, 15, 172-176.

[5]        H. Russo, J. Brès, M.P. Duboin, B. Roquefeuil., Eur. J. Clin. Pharmacol., 1995, 49, 127–137.

[6]        D.J. Morgan, G.L. Blackman, J.D. Paull, L.J. Wolf, Anesthesiology, 1981, 54, 474–480.

[7]        M.M. Margaret, C. Beyer, B.R. Komisaruk, Pharmacology Biochemistry and Behavior, 1989, 32, 897-900.

[8]        A. Kushikata, T. Hirota, K. Yoshida, H. Kudo, M. Lambert, D.G. Smart, D. Jerman, J.C. Matsuki, Neuroscience., 2003, 121, 855-863.

[9]        H. Downes, D.R. Koop, B. Klopfenstein, N. Lessov, Comparative Biochemistry and Physiology, 1999,124, 203-210.

[10]      H.K. Zak, FEBS Letters, 1976, 63, 149-153.

[11]      K.h. Mohammed Khan, A. Wadood, Z. Ulhaq, M. Khan, M. Arif Lodhi, H. Perveen, M. Iqbal Choudhary, W. Voelter, Journal of Molecular Graphics and Modelling., 2011,30, 153-156

[12]      Dhirendra Mehta, Edwin L. Bradley Jr., Igor Kissin., Journal of Clinical Anesthesia, 1991,3, 280-284.

[13]      J.C. Mucklow, Side Effects of Drugs Annual, 1989,13, 50-55.

[14]      S. Ahadi, M. Abaszadeh, H.R. Khavasi, A. Bazgir, Tetrahedron,2012, 68, 2906-2916.

[15]      J. Daniel Figueroa-Villar, A.A. Vieira, Journal of Molecular Structure,2013, 1034, 310-317.

[16]      M.d. Amin Hasan, A. Seshaditya, S. Zalis, L. Mishra, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.,2011, 83, 532-539.

[17]      A.J. Davies, xPharm. The Comprehensive Pharmacology Reference, 2007, 1-4.

[18]      M.J. McLeish., Analytical Profiles of Drug Substances and Excipients, 1992,21, 535-572.

[19]      V.M. Okudzhara,, A. Izv, N. Gruz, Ser. Biol. 1988,14, 58-66.

[20]      L.V. Jones, M.J. Whilehouse, Biomed. Mass Spectrum, 1981,8,226-231.

[21] V.I. Popora, V.F. Kramarenko, Farmatsia (Moscow),1974,23, 148-157.